Heikki Valleala

1.1k citations
27 papers · 889 indexed · h-index 13

Heikki Valleala

27 papers receiving 863 citations

Peers

Heikki Valleala
Comparison fields: 5 of 87
  • Rheumatology 413
  • Cancer Research 237
  • Orthopedics and Sports Medicine 122
  • Hematology 155
  • Oncology 273
Replace Jesús Álvarez with:
Jesús Álvarez Spain
N.S. Gudmann Denmark
Toru Yago Japan
Piyanka Chandra United States
Manali Bendre United States
Ulrike Harre Germany
M Keysser Germany
Masahiko Tsuboi Japan
Uriel M. Malyankar United States
Kathy Rohrbach United States
Heikki Valleala relative to Jesús Álvarez Spain Jesús Álvarez's profile →
Citations per field
00.5×1.7×
Jesús Álvarez · 1×
Citations per year

Countries citing papers authored by Heikki Valleala

Since Specialization
Citations

This map shows the geographic impact of Heikki Valleala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heikki Valleala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heikki Valleala more than expected).

Fields of papers citing papers by Heikki Valleala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heikki Valleala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heikki Valleala. The network helps show where Heikki Valleala may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Heikki Valleala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heikki Valleala Line = papers co-authored together Heikki Valleala links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20167
2
A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs.
201610
3 201518
4 201510
5 201565
6 20154
7 20144
8 20131
9 201240
10 201015
11 201024
12 20099
13 200912
14 200811
15 20074
16 200340
17 20019
18 1999342
19 199968
20 199761

About Heikki Valleala

Heikki Valleala is a scholar working on Rheumatology, Genetics and Family Practice, having authored 27 papers that have together received 889 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (13 papers), Bone health and treatments (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Protease and Inhibitor Mechanisms (5 papers), Systemic Lupus Erythematosus Research (5 papers), Bone Metabolism and Diseases (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Mycobacterium research and diagnosis (4 papers). The work is most often cited by research in Rheumatology (413 citations), Cancer Research (237 citations) and Orthopedics and Sports Medicine (122 citations). Heikki Valleala has collaborated with scholars based in Finland, Netherlands and India. Frequent co-authors include Yrjö T. Konttinen, Seppo Santavirta, Timo Sorsa, Carlos López-Otı́n, Mari Ainola, Jin Ma, Jami Mandelin, Hideo Ida, Michiaki Takagi and Raimund W. Kinne. Their work appears in journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026